Are the physicochemical properties of antibacterial compounds really different from other drugs?

BackgroundIt is now widely recognized that there is an urgent need for new antibacterial drugs, with novel mechanisms of action, to combat the rise of multi-drug resistant bacteria. However, few new compounds are reaching the market. Antibacterial drug discovery projects often succeed in identifying potent molecules in biochemical assays but have been beset by difficulties in obtaining antibacterial activity. A commonly held view, based on analysis of marketed antibacterial compounds, is that antibacterial drugs possess very different physicochemical properties to other drugs, and that this profile is required for antibacterial activity.ResultsWe have re-examined this issue by performing a cheminformatics analysis of the literature data available in the ChEMBL database. The physicochemical properties of compounds with a recorded activity in an antibacterial assay were calculated and compared to two other datasets extracted from ChEMBL, marketed antibacterials and drugs marketed for other therapeutic indications. The chemical class of the compounds and Gram-negative/Gram-positive profile were also investigated. This analysis shows that compounds with antibacterial activity have physicochemical property profiles very similar to other drug classes.ConclusionsThe observation that many current antibacterial drugs lie in regions of physicochemical property space far from conventional small molecule therapeutics is correct. However, the inference that a compound must lie in one of these “outlier” regions in order to possess antibacterial activity is not supported by our analysis.

• Publication year

  2016

• Venue

  Journal of Cheminformatics

• Publication date

  2016-06-03

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1186/s13321-016-0143-5PMID 27274770PMCID 4891840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A New-Class Antibacterial-Almost. Lessons in Drug Discovery and Development: A Critical Analysis of More than 50 Years of Effort toward ATPase Inhibitors of DNA Gyrase and Topoisomerase IV.

  2015cited by this paper
• ESKAPEing the labyrinth of antibacterial discovery

  2015cited by this paper
• The relationship between target-class and the physicochemical properties of antibacterial drugs

  2015cited by this paper
• Toward the rational design of carbapenem uptake in Pseudomonas aeruginosa.

  2015cited by this paper
• Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors

  2014cited by this paper
• Trends and exceptions of physical properties on antibacterial activity for Gram-positive and Gram-negative pathogens.

  2014influential reference
• General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria

  2014cited by this paper
• Base substituted 5'-O-(N-isoleucyl)sulfamoyl nucleoside analogues as potential antibacterial agents.

  2014cited by this paper
• The ChEMBL bioactivity database: an update

  2013cited by this paper
• Characterization of Peptide Chain Length and Constituency Requirements for YejABEF-Mediated Uptake of Microcin C Analogues

  2011cited by this paper
• Physicochemical properties of antibacterial compounds: implications for drug discovery.

  2008influential reference
• Optimization of CAMD techniques 3. Virtual screening enrichment studies: a help or hindrance in tool selection?

  2008cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Lead Discovery Using Stochastic Cluster Analysis (SCA): A New Method for Clustering Structurally Similar Compounds

  1998cited by this paper

• Predictive modelling of peroxisome proliferator-activated receptor gamma (PPARγ) IC50 inhibition by emerging pollutants using light gradient boosting machine

  2025cites this paper
• Novel small molecule targeting PgQC reduces Porphyromonas gingivalis virulence

  2025cites this paper
• A Review of the Zinc Oxide Nanoparticles Synthesis and Their Emerging Biomedical Potential

  2025cites this paper
• Synthesis and Characterization of Two Sparfloxacin Crystalline Salts: Enhancing Solubility and In Vitro Antibacterial Activity of Sparfloxacin

  2024cites this paper
• Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo Efficacy.

  2024cites this paper
• 1,2,3-Triazol-5-ylidene- vs. 1,2,3-triazole-based tricarbonylrhenium(I) complexes: influence of a mesoionic carbene ligand on the electronic and biological properties.

  2024cites this paper
• Machine Learning-Based Virtual Screening of Antibacterial Agents against Methicillin-Susceptible and Resistant Staphylococcus aureus

  2024cites this paper
• Rational design of novel compounds to serve as potential NDM-1 inhibitors using molecular docking, molecular dynamics simulation, and physicochemical studies

  2023cites this paper
• Isatin Bis-Indole and Bis-Imidazothiazole Hybrids: Synthesis and Antimicrobial Activity

  2022cites this paper
• On the ability of machine learning methods to discover novel scaffolds

  2022cites this paper
• SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.

  2022cites this paper
• Acylhydrazones and Their Biological Activity: A Review

  2022cites this paper
• Microbial community interactions on a chip

  2022cites this paper
• Poly(alkyl ether) based ionic liquid–γ-cyclodextrin based inclusion complex and antibacterial activity of the inclusion complex

  2022cites this paper
• Challenges in Drug Discovery for Intracellular Bacteria

  2021cites this paper
• Facile synthesis and biological evaluation of chrysin derivatives

  2021cites this paper
• A review on adsorbents for the remediation of wastewater: Antibacterial and adsorption study

  2021cites this paper
• Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors.

  2021cites this paper
• Empirical Analysis Revealing Privileged Chemical Space of Cosmetic Preservatives

  2021cites this paper
• Towards machine learning discovery of dual antibacterial drug-nanoparticle systems.

  2021cites this paper
• Compound Prioritization through Meta-Analysis Enhances the Discovery of Antimicrobial Hits against Bacterial Pathogens

  2021cites this paper
• U.S. FDA Approved Drugs from 2015-June 2020: A Perspective.

  2021cites this paper
• Cheminformatic Characterization of Natural Antimicrobial Products for the Development of New Lead Compounds

  2021cites this paper
• The Demand for New Antibiotics: Antimicrobial Peptides, Nanoparticles, and Combinatorial Therapies as Future Strategies in Antibacterial Agent Design

  2020cites this paper
• Testicular Caspase-3 and β-Catenin Regulators Predicted via Comparative Metabolomics and Docking Studies

  2020cites this paper
• Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold.

  2020cites this paper
• Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (Amphimedon) Species in Green Synthesized Silver Nanoparticles Assisted by in Silico Modeling and Metabolic Profiling

  2020cites this paper
• Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli

  2020cites this paper
• Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening

  2020cites this paper
• Perspective on Antibacterial Lead Identification Challenges and the Role of Hypothesis-Driven Strategies

  2019cites this paper
• Enabling design of screening libraries for antibiotic discovery by modeling ChEMBL data.

  2019cites this paper
• Small Polar Hits against S. aureus: Screening, Initial Hit Optimization, and Metabolomic Studies

  2019cites this paper
• Synthesis of Disulfide‐Bridged N‐Phenyl‐N′‐(alkyl/aryl/heteroaryl)urea Derivatives and Evaluation of Their Antimicrobial Activities

  2019cites this paper
• Virtual screening approach and biochemical evaluation on MurB

  2019cites this paper
• The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.

  2019cites this paper
• Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity.

  2019cites this paper
• Targeting the bacterial membrane with a new polycyclic privileged structure: a powerful tool to face Staphylococcus aureus infections.

  2019cites this paper
• Mechanistic Study on the Antibacterial Activity of Self-Assembled Poly(aryl ether)-Based Amphiphilic Dendrimers.

  2019cites this paper
• Efficient discovery of novel antimicrobials through integration of synthesis and testing in crude ribosome extract.

  2019cites this paper
• Potential of marine natural products against drug-resistant bacterial infections.

  2019cites this paper
• Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.

  2019cites this paper
• Novel narrow spectrum benzyl thiophene sulfonamide derivatives to control Campylobacter

  2019cites this paper
• Amino acid conjugated antimicrobial drugs: Synthesis, lipophilicity- activity relationship, antibacterial and urease inhibition activity.

  2018cites this paper
• A Computer-Driven Approach to Discover Natural Product Leads for Methicillin-Resistant Staphylococcus aureus Infection Therapy

  2018cites this paper
• 1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity.

  2018cites this paper
• Cheminformatics in the Service of GPCR Drug Discovery.

  2018cites this paper
• Overcoming problems of poor drug penetration into bacteria: challenges and strategies for medicinal chemists

  2018cites this paper
• Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

  2018cites this paper
• ((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies.

  2018cites this paper
• ANTIBACTERIAL AND CYTOTOXIC POTENCIES OF STILBENE OLIGOMERS FROM STEM BARKS OF BAOTI (DRYOBALANOPS LANCEOLATA) GROWING IN KENDARI, INDONESIA

  2017cites this paper